Consumption and costs of antihypertensive drugs in Mexico: Are diuretic agents a standing technological trajectory?-Reference-Cited by-同舟云学术

Consumption and costs of antihypertensive drugs in Mexico: Are diuretic agents a standing technological trajectory?

Published:2006-03 Issue:1 Volume:2 Page:22-37
ISSN:1551-7411
Container-title:Research in Social and Administrative Pharmacy
language:en
Short-container-title:Research in Social and Administrative Pharmacy

Author:

Altagracia-Martínez M.,Kravzov-Jinich J.,Guadarrama-Atrizco M.D.,Rubio-Poo C.,Wertheimer A.I.

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacy

Reference31 articles.

1. Scrip Report. Hypertension: therapeutic advances and market opportunities (BS 888);PJB Publ,1997

2. The new “1999 World Health Organisation–International Society of Hypertension (WHO-ISH). Guidelines for the Management of Hypertension”. Guidelines set new definitions, update treatment for hypertension;Bull World Health Organ,1999

3. Mexico. A Comprehensive Development Agenda for the New Era;Giugale,2001

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends of Antihypertensive, Antidiabetic, and Nonsteroidal Anti-Inflammatory Drugs Use among the Health Workers Cohort Study, Mexico 2004 to 2018;Advances in Pharmacological and Pharmaceutical Sciences;2023-11-21

2. Analysis of Chronic Disease Direct Cost at Public Primary Health Cares in Indonesia;Bangladesh Journal of Medical Science;2021-06-18

3. Les médicaments génériques et l’évolution de la consommation des antihypertenseurs au Maroc;Therapies;2013-09

4. The fuzzy line between needs, coverage, and excess in the Mexican Formulary List: an example of qualitative market width analysis;European Journal of Clinical Pharmacology;2012-10-23